Related Experiment Video

Updated: Jul 15, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Childhood multiple sclerosis treated with plasmapheresis

I Takahashi1, Y Sawaishi, O Takeda

  • 1Department of Pediatrics, Akita University School of Medicine, Japan.

Pediatric Neurology
|July 1, 1997
PubMed

Insights

Plasmapheresis offers a promising alternative treatment for pediatric multiple sclerosis, particularly in severe or steroid-dependent cases. This therapy led to sustained remission in a young patient, suggesting its potential for long-term management.

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Pediatric MS is rare, and treatment options, especially for severe or steroid-dependent cases, require further investigation.
  • High-dose corticosteroid therapy, while effective, carries significant side effects with frequent administration.

Observation:

  • A 7-year-old boy experienced three relapses of MS within 8 months, requiring repeated high-dose methylprednisolone treatment.
  • To mitigate steroid-related side effects, plasmapheresis was initiated during the third relapse.
  • Treatment involved initial plasmapheresis for 3 days, followed by intermittent sessions guided by antinuclear antibody (ANA) titers.

Findings:

  • The patient demonstrated marked clinical improvement following the introduction of plasmapheresis.
  • The boy remained relapse-free for over 18 months after commencing plasmapheresis.
  • This case highlights the potential efficacy of plasmapheresis in managing pediatric MS, particularly when linked to fluctuating ANA levels.

Implications:

  • Plasmapheresis may serve as a valuable alternative or adjunctive therapy for steroid-dependent or severe pediatric multiple sclerosis.
  • Monitoring antinuclear antibody titers could be a useful strategy in assessing disease activity and guiding plasmapheresis treatment in children.
  • Further research is warranted to establish the long-term safety and efficacy of plasmapheresis in the pediatric MS population.

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...